HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 15 August 2013

Project update: DSU reports

Two recent NICE Technology Appraisals have been recently published online; NICE is not recommending belimumab for lupus and is recommending dapagliflozin for diabetes. The NICE Decision Support Unit, based in HEDS, contributed reports to both appraisals. Visit the DSU website for more details.